Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass

Published:2022-12 Issue: Volume:368 Page:62-68
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Peng Yun-Wen,Major Terry,Deatrick Kristopher B.,Mohammed Azmath,Jeakle Mark,Charpie John R.

Funder

Medical School, University of Michigan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Nicorandil: a drug with ongoing benefits and different mechanisms in various diseased conditions;Ahmed;Indian J. Pharm.,2019

2. Nicorandil, a nitric oxide donor and ATP-sensitive potassium channel opener, protects against dystrophin-deficient cardiomyopathy;Afzal;J. Cardiovasc. Pharmacol. Ther.,2016

3. Cardioprotective effect of nicorandil against myocardial injury following cardiac arrest in swine;Liang;Am. J. Emerg. Med.,2017

4. Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K/Akt signaling pathway;Wu;Cell. Physiol. Biochem.,2015

5. Protective mechanism of nicorandil on rat myocardial ischemia-reperfusion;Wang;J. Cardiovasc. Med.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Perioperative Nicorandil on Myocardial Protection in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass, a Retrospective Study;Drug Design, Development and Therapy;2024-01

2. Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts—A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol;Advances in Therapy;2023-06-17

3. A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023;Frontiers in Cardiovascular Medicine;2023-06-13

4. Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy;Cells;2023-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3